New vaccine could ‘wipe out’ ovarian cancer – what does it mean and when will it be ready? - Ovarian cancer is notorious for causing very minimal symptoms in the early stages.

In this study, the Cancer Research UK-funded scientists will establish the targets for the vaccine. They will find out which proteins on the surface of early-stage ovarian cancer cells are most strongly recognized by the immune system and how effectively the vaccine kills mini-models of ovarian cancer called organoids.

The vaccines are still in early development, but if tests are successful, they could help prevent one of the most common forms of cancer for women.

A first-ever ovarian cancer vaccine – currently being developed by the University of Oxford hopes to wipe off the deadly cancer – which kills thousands of women across the world yearly. According to scientists – the jab could be given to all women preventatively to eliminate the disease,